These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4003098)

  • 21. Differential expression of complement C3 and C4 in the human kidney.
    Welch TR; Beischel LS; Witte DP
    J Clin Invest; 1993 Sep; 92(3):1451-8. PubMed ID: 8376597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort.
    Ritchie RF; Palomaki GE; Neveux LM; Navolotskaia O; Ledue TB; Craig WY
    J Clin Lab Anal; 2004; 18(1):1-8. PubMed ID: 14730550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The C3, C3 Att and C4 fractions of complement in chronic hepatitis: preliminary data].
    Riegler G; Ciotola R; Di Simone A
    Boll Soc Ital Biol Sper; 1976 Feb; 52(4):200-3. PubMed ID: 952675
    [No Abstract]   [Full Text] [Related]  

  • 24. [Complement C3 and C4 levels in serum from acute viral hepatitis].
    Ozer FT; Barut A; Inal A; Hacibektaşoğlu A
    Mikrobiyol Bul; 1992 Oct; 26(4):314-9. PubMed ID: 1435361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acidotropic compounds on the secretory pathway: inhibition of secretion and processing of the third and fourth components of complement.
    Hortin G; Strauss AW
    Biochem Biophys Res Commun; 1986 Apr; 136(2):603-9. PubMed ID: 3010984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells.
    Sacks S; Zhou W; Campbell RD; Martin J
    Clin Exp Immunol; 1993 Sep; 93(3):411-7. PubMed ID: 8370168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment.
    El-Fatah Fahmy Hanno A; Mohiedeen KM; Deghedy A; Sayed R
    Arab J Gastroenterol; 2014 Jun; 15(2):58-62. PubMed ID: 25097047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.
    Strunk RC; Eidlen DM; Mason RJ
    J Clin Invest; 1988 May; 81(5):1419-26. PubMed ID: 2966814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparative study of serum complement (C3 and C4) in inflammatory joint diseases].
    Dacheva V; Dimov DM; Nedialkova V; Koleva P
    Vutr Boles; 1990; 29(5):68-74. PubMed ID: 1706901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2.
    Andoh A; Fujiyama Y; Bamba T; Hosoda S
    J Immunol; 1993 Oct; 151(8):4239-47. PubMed ID: 8409399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of reference intervals for serum complement C3 and C4 levels in Chinese Han ethnic males.
    Qin X; Lu Y; Yang X; Peng Q; Wang J; Mo C; Wu J; Sui J; Liu Y; Huang X; Zhai L; Yang S; Li R; Li S; Yang X; Gao Y; Mo Z
    Clin Lab; 2014; 60(5):775-81. PubMed ID: 24839820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunoglobulins and C3 and C4 complement components in chronic hepatitis B].
    Stránský J; Votruba T; Zichová M; Vodák M; Benda R
    Cas Lek Cesk; 1985 Nov; 124(47):1445-50. PubMed ID: 4064094
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation.
    Dernellis J; Panaretou M
    Am J Cardiol; 2006 Jan; 97(2):245-8. PubMed ID: 16442371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man.
    Lai A Fat RF; van Furth R
    Immunology; 1975 Feb; 28(2):359-68. PubMed ID: 804438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the Optilite
    Nespola B; Comitogianni H; Jahn I; Goetz J
    Ann Biol Clin (Paris); 2019 Aug; 77(4):447-452. PubMed ID: 31339492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum complement C4 in chronic hepatitis C: correlation with histopathologic findings and disease activity.
    Buğdaci MS; Karaca C; Alkim C; Kesıcı B; Bayraktar B; Sökmen M
    Turk J Gastroenterol; 2012 Feb; 23(1):33-7. PubMed ID: 22505377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation and fragmentation of the third (C3) and the fourth (C4) components of complement: generation and isolation of physiologically relevant fragments C3c and C4c.
    Janatova J; Gobel RJ
    J Immunol Methods; 1985 Dec; 85(1):17-26. PubMed ID: 4078308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The third (C3) and the fourth (C4) components of complement: labile binding site and covalent bond formation.
    Janatova J
    Ann N Y Acad Sci; 1983; 421():218-34. PubMed ID: 6586100
    [No Abstract]   [Full Text] [Related]  

  • 40. Complement localization in ischemic baboon myocardium.
    McManus LM; Kolb WP; Crawford MH; O'Rourke RA; Grover FL; Pinckard RN
    Lab Invest; 1983 Apr; 48(4):436-47. PubMed ID: 6339810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.